The global market for Infection Surveillance Solutions was estimated at US$852.9 Million in 2024 and is projected to reach US$2.1 Billion by 2030, growing at a CAGR of 16.3% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Infection Surveillance Solutions market.
Global Infection Surveillance Solutions Market - Key Trends & Drivers Summarized
What Are Infection Surveillance Solutions and Why Are They Critical?
Infection surveillance solutions are systems and software used by healthcare facilities to monitor and prevent the occurrence and spread of infections within healthcare settings. These systems collect, analyze, and interpret health data to identify potential infection outbreaks and to ensure timely intervention. Such solutions are crucial for maintaining patient safety, managing antimicrobial resistance, and enhancing the overall quality of healthcare services. They track various indicators, including the types of infections, the points of origin within the facility, and the effectiveness of infection control measures. This ongoing surveillance supports hospitals in adhering to regulatory standards and improving patient outcomes.How Is Technology Enhancing Infection Control?
Advancements in technology have significantly bolstered the capabilities of infection surveillance solutions. Modern systems integrate electronic health records (EHRs), real-time data monitoring, and advanced analytics to provide comprehensive surveillance capabilities. Artificial intelligence (AI) and machine learning (ML) are increasingly being employed to predict infection risks and outbreak patterns, thereby enabling proactive measures. Additionally, mobile platforms enhance the accessibility of surveillance data, facilitating faster response times and improved coordination among healthcare teams. These technological improvements not only increase the efficiency of data management but also enhance the accuracy of infection tracking and the effectiveness of preventive strategies.What Impact Does Regulatory Compliance Have on the Adoption of These Systems?
Regulatory compliance is a significant driver for the adoption of infection surveillance solutions. In many regions, health authorities require healthcare facilities to implement robust infection control programs to maintain accreditation and receive funding. For instance, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) both provide guidelines and standards for infection surveillance and control. Compliance with these regulations necessitates the adoption of sophisticated surveillance systems capable of providing detailed and accurate data reporting. As regulatory frameworks around the world tighten and focus more on patient safety and quality of care, healthcare providers are increasingly reliant on these solutions to meet their compliance and care standards.What Drives Growth in the Infection Surveillance Solutions Market?
The growth in the infection surveillance solutions market is driven by several factors, including increasing healthcare-associated infection rates, technological advancements, and stringent regulatory requirements. The rising prevalence of chronic diseases and subsequent increase in hospital stays have also escalated the risk of healthcare-associated infections, thereby boosting the demand for effective surveillance systems. Technological innovations, such as integration with electronic health records and real-time analytics, have enhanced the efficiency and efficacy of these systems. Additionally, the growing global emphasis on healthcare quality and patient safety, supported by government initiatives and funding for health infrastructure, has propelled the adoption of advanced surveillance solutionsSCOPE OF STUDY:
The report analyzes the Infection Surveillance Solutions market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Type (Software, Services); End-Use (Hospitals, Long-Term Care Facilities, Other End-Uses)
- Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Software segment, which is expected to reach US$1.3 Billion by 2030 with a CAGR of a 15.6%. The Services segment is also set to grow at 17.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $278.7 Million in 2024, and China, forecasted to grow at an impressive 17.3% CAGR to reach $233.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Infection Surveillance Solutions Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Infection Surveillance Solutions Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Infection Surveillance Solutions Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as IBM Corporation, Becton, Dickinson and Company, bioMerieux SA, Illumina, Inc., Cerner Corporation and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 40 companies featured in this Infection Surveillance Solutions market report include:
- IBM Corporation
- Becton, Dickinson and Company
- bioMerieux SA
- Illumina, Inc.
- Cerner Corporation
- Ecolab, Inc.
- Gojo Industries, Inc.
- Epic Systems Corporation
- CenTrak, Inc.
- Iatric Systems, Inc.
- Harris Healthcare
- Perahealth, Inc.
- ABILITY Network Inc.
- Asolva, Inc.
- ICNet International
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- IBM Corporation
- Becton, Dickinson and Company
- bioMerieux SA
- Illumina, Inc.
- Cerner Corporation
- Ecolab, Inc.
- Gojo Industries, Inc.
- Epic Systems Corporation
- CenTrak, Inc.
- Iatric Systems, Inc.
- Harris Healthcare
- Perahealth, Inc.
- ABILITY Network Inc.
- Asolva, Inc.
- ICNet International
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 254 |
| Published | July 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 852.9 Million |
| Forecasted Market Value ( USD | $ 2100 Million |
| Compound Annual Growth Rate | 16.3% |
| Regions Covered | Global |
